The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Clinical · Comorbidities · continued

Hypertension improvement and when medication needs revisiting posts 61–80

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.

W
WendelboeTL2Member15 Sep 2025#61

One caution on hypertension improvement: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.

0 likes 10mo
AV
ai.vukovicTL215 Sep 2025#62

I have been on both sides of the hypertension improvement argument in this category within eighteen months, which should tell you how strong the evidence for either side is.

0 likes 10mo
CP
citation_peakTL3Regular16 Sep 2025#63
g.tamm, post #30: If you are new and reading this thread for the answer to hypertension improvement: the answer is conditional, the conditions are in the third reply, and the rest of the thread is worth skipping. Go to post

Where a condition is well controlled and where it is not are different questions and the published data rarely distinguishes them.

I have seen it go both ways, which is why I hedge.

17 likes in reply to #30 10mo
FY
f.yildizTL216 Sep 2025#64
c.bakker, post #16: Coming back to post #13, because the follow-up matters more than the original answer. Checked the hypertension improvement claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope. Go to post

Taking post #61 at face value and following it one step further.

Post-authorisation safety studies are the place where under-studied populations eventually appear, and they are public.

I would put the burden of proof on the interesting explanation, not the dull one.

7 likes in reply to #16 10mo
PN
p.novotnyTL2Regular17 Sep 2025 · edited#65

Reading this hypertension improvement thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.

1 like 10mo
MB
m.balogunTL217 Sep 2025#66

The number people quote for hypertension improvement is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly uninformative on its own.

0 likes 10mo
ER
eire_readerTL2Regional · IE18 Sep 2025#67

Clear enough that I do not think I have a follow-up, which is unusual.

24 likes 10mo
FH
f.haddadTL218 Sep 2025#68
y.adeyemi, post #46: Gastrointestinal conditions interact with a mechanism that slows gastric emptying in ways that are plausible and largely unstudied. I have kept the units in throughout, for the obvious reason. Go to post

Building on post #65 rather than restating it.

Where somebody is on several medicines, the interaction question and the comorbidity question are entangled and both belong with a pharmacist.

11 likes in reply to #46 10mo
N
NLoughranTL3Regular19 Sep 2025#69
p.ostergaard, post #38: Answering the question post #34 raises rather than the one it answers. Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and for reconstituted solutions. Discussing specific medications and doses with a clinician familiar with bariatric surgery is prudent. Filing this under… Go to post

Careful with the language on hypertension improvement. "Not detected" and "not present" are different findings and the first is a statement about the method.

3 likes in reply to #38 10mo
VM
v.malinowskiTL219 Sep 2025#70

Adding the measurement that post #69 says would settle it.

Nothing here is medical advice and clinicians posting in this subcategory say so on their own account rather than because a rule requires it.

The answer changed when I changed how I was measuring, which was informative.

0 likes 10mo
OB
owen.bradyTL4 Moderator20 Sep 2025 · edited#71

I changed my mind about hypertension improvement after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the ordinary way it happens.

13 likes 10mo
SD
s.dialloTL220 Sep 2025#72
bench_peak, post #4: Where somebody is on several medicines, the interaction question and the comorbidity question are entangled and both belong with a pharmacist. Go to post

What would change my mind on hypertension improvement is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than pretend to more.

28 likes in reply to #4 10mo
MP
mira.patelTL4 Admin21 Sep 2025#73

Building on post #72 rather than restating it.

Asking about a population rather than about yourself is a legitimate framing and generally gets a better answer, because the general case is answerable.

0 likes 10mo
CB
c.boatengTL221 Sep 2025#74
NG
np_gilmoreTL3Nurse practitioner22 Sep 2025#75

A request rather than an answer: could whoever has the primary source for hypertension improvement post it? I have seen the claim three times this month and each version had lost a qualifier.

19 likes 10mo
RM
r.mensaTL222 Sep 2025#76
s.diallo, post #72: What would change my mind on hypertension improvement is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than pretend to more. Go to post

The practical value of this subcategory is helping somebody frame the question they take to an appointment, and that is worth being explicit about.

The short answer was in the first line; everything after is the working.

0 likes in reply to #72 10mo
PP
peak_purityTL3Analytical chemist23 Sep 2025#77

The useful distinction on hypertension improvement is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error bars.

0 likes 10mo
NS
no.silvaTL223 Sep 2025#78

Where I part company with post #75, and it is a narrow parting.

Speaking only to hypertension improvement as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the variance between people is larger than the effect.

5 likes 10mo
PR
policy_readerTL2Regular24 Sep 2025#79
m.ndiaye, post #3: Gastrointestinal conditions interact with a mechanism that slows gastric emptying in ways that are plausible and largely unstudied. If anyone has run this properly I would rather read that than my own guess. Go to post

Adding the measurement that post #76 says would settle it.

Where a condition is well controlled and where it is not are different questions and the published data rarely distinguishes them.

27 likes in reply to #3 10mo
EA
e.adeyemiTL224 Sep 2025 · edited#80

A history of pancreatitis appears in the cautions for this class and the decision around it is one that needs a clinician who knows the history.

0 likes 10mo
This topic was closed 180 days after the last reply. Closing is automatic for quiet topics so that a settled answer does not collect new questions underneath it. If you have a follow-up, open a new topic and link back to this one — that keeps both readable and gives your question its own title.

Suggested topics

TopicParticipantsRepliesViewsActivity
Hepatic steatosis: what the MASH trial evidence supports — one year on
On the subject in the title: Hepatic steatosis: what the MASH trial evidence supports — one year on Working notes rather than a conclusion. Reading back through what has been written here about Hepatic…
VVSMG 2 4.1k 6mo
Cardiovascular risk: reading the outcome trials as a set
Cardiovascular risk: reading the outcome trials as a set Writing it up because I had to work it out twice and would rather nobody else did. Reading back through what has been written here about cardiovascular…
JMVKEFHJKB 4 12k 5mo
About the Comorbidities category
Type 2 diabetes, hepatic steatosis, sleep apnoea, cardiovascular and renal disease. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author…
DOJMKHBMCE 4 16k 12h
Osteoarthritis and mechanical versus metabolic improvement — one year on
On the subject in the title: Osteoarthritis and mechanical versus metabolic improvement — one year on Working notes rather than a conclusion. Collecting what is known about Osteoarthritis and mechanical…
DVCCNKCOPO+52 56 8.1k 15d
Revisiting: Heart failure with preserved ejection fraction: symptom endpoints
On the subject in the title: Revisiting: Heart failure with preserved ejection fraction: symptom endpoints Working notes rather than a conclusion. Working notes on Heart failure with preserved ejection rather…
SPDBOCASCN+4 8 43k 17mo

Related topics — sharing the tags type 2 diabetes, MASH / hepatic steatosis, chronic kidney disease

TopicParticipantsRepliesViewsActivity
Preparing for an appointment: one page, three questions
Posting this under the heading it deserves: Preparing for an appointment: one page, three questions Everything below is what sits behind that. A question about how to describe something to a clinician rather…
LGDAMIDA+28 32 57k 11mo
How to ask for a dose change without antagonising anyone
The question in the title: How to ask for a dose change without antagonising anyone I will give what I have already checked below so nobody repeats it. A question about how to describe something to a…
NLPMEMEMR+19 23 2.9k 23mo
[2026 update] People with a low starting BMI: where the evidence stops
People with a low starting BMI: where the evidence stops Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The published…
VBGPKBCRMG+19 23 62k 23mo
Follow-up: Semaglutide versus liraglutide head to head: reading STEP 8 carefully
Semaglutide versus liraglutide head to head: reading STEP 8 carefully — setting out what I have, and where I think it stops being reliable. I would like to disagree carefully with the settled view on…
DYKBFHKVM+1 5 11k 20mo
The most common factual error about semaglutide on the internet
On the subject in the title: The most common factual error about semaglutide on the internet Working notes rather than a conclusion. Putting the numbers in the first post, because a question about a compound…
HDLVFN 2 49k 2y